Zobrazeno 1 - 10
of 567
pro vyhledávání: '"David C. Wheeler"'
Autor:
Eleni Stamellou, Turgay Saritas, Marc Froissart, Florian Kronenberg, Peter Stenvinkel, David C. Wheeler, Kai-Uwe Eckardt, Jürgen Floege, James Fotheringham
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-9 (2024)
Abstract Background The consequences of chronic kidney disease (CKD) can be addressed with a range of pharmacotherapies primarily prescribed by nephrologists. More accurate information regarding future CKD-related pharmacotherapy requirements could g
Externí odkaz:
https://doaj.org/article/17720dd38736438e84f2e30296ffc31c
Autor:
Glenn M. Chertow, Hiddo Lambers Heerspink, Patrick B. Mark, Jamie P. Dwyer, Michal Nowicki, David C. Wheeler, Ricardo Correa-Rotter, Peter Rossing, Robert D. Toto, Anna Maria Langkilde, Niels Jongs
Publikováno v:
Glomerular Diseases (2024)
Introduction Despite the provision of renin-angiotensin-aldosterone-system inhibitors and immunosuppressive therapies, membranous nephropathy often progresses to end-stage kidney disease (ESKD). The objective of this prespecified analysis was to asse
Externí odkaz:
https://doaj.org/article/f7c6397ab9254160bd340782cae6b634
Autor:
Hannah M. L. Young, Ellen M. Castle, Juliet Briggs, Christy Walklin, Roseanne E. Billany, Elham Asgari, Sunil Bhandari, Nicolette Bishop, Kate Bramham, James O. Burton, Jackie Campbell, Joseph Chilcot, Nicola Cooper, Vashist Deelchand, Matthew P. M. Graham-Brown, Lynda Haggis, Alexander Hamilton, Mark Jesky, Philip A. Kalra, Pelagia Koufaki, Jamie Macdonald, Kieran McCafferty, Andrew C. Nixon, Helen Noble, Zoe L. Saynor, Maarten W. Taal, James Tollitt, David C. Wheeler, Thomas J. Wilkinson, Sharlene A. Greenwood
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-21 (2024)
Abstract This trial assessed the feasibility and acceptability of Kidney BEAM, a physical activity and emotional well-being self-management digital health intervention (DHI) for people with chronic kidney disease (CKD), which offers live and on-deman
Externí odkaz:
https://doaj.org/article/929daa35b9e5447792f36af5ef3b5899
Autor:
Shannon M. Monnat, David C. Wheeler, Emily Wiemers, Yue Sun, Xinxin Sun, Douglas A. Wolf, Jennifer Karas Montez
Publikováno v:
Preventive Medicine Reports, Vol 35, Iss , Pp 102370- (2023)
In the early months of the COVID-19 pandemic, states enacted multiple policies to reduce in-person interactions. Scholars have speculated that these policies may have contributed to adverse mental health outcomes. This study examines potential associ
Externí odkaz:
https://doaj.org/article/5c5995c7c8d44b8784cf7fc43f2b54bd
Autor:
Thomas Forst, Chantal Mathieu, Francesco Giorgino, David C. Wheeler, Nikolaos Papanas, Roland E. Schmieder, Atef Halabi, Oliver Schnell, Marina Streckbein, Katherine R. Tuttle
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-15 (2022)
Abstract Background Diabetic kidney disease (DKD), the most common cause of kidney failure and end-stage kidney disease worldwide, will develop in almost half of all people with type 2 diabetes. With the incidence of type 2 diabetes continuing to inc
Externí odkaz:
https://doaj.org/article/62020e62af414e208c77428994711e7b
Autor:
Glenn M. Chertow, Ricardo Correa‐Rotter, Priya Vart, Niels Jongs, John J. V. McMurray, Peter Rossing, Anna Maria Langkilde, C. David Sjöström, Robert D. Toto, David C. Wheeler, Hiddo J. L. Heerspink
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 9 (2023)
Background The DAPA‐CKD (Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease) trial (NCT03036150) demonstrated that dapagliflozin reduced the risk of kidney and cardiovascular events in patients with chronic kidney disease an
Externí odkaz:
https://doaj.org/article/9826f32decaf40029c4ae4917e251524
Autor:
Sharlene A. Greenwood, Nicholas Beckley-Hoelscher, Elham Asgari, Salma Ayis, Luke A. Baker, Debasish Banerjee, Sunil Bhandari, Kate Bramham, Joseph Chilcot, James Burton, Philip A. Kalra, Courtney J. Lightfoot, Kieran McCafferty, Thomas H. Mercer, Darlington O. Okonko, Benjamin Oliveira, Chante Reid, Alice C. Smith, Pauline A. Swift, Anastasios Mangelis, Emma Watson, David C. Wheeler, Thomas J. Wilkinson, Fiona Reid, Iain C. Macdougall
Publikováno v:
BMC Nephrology, Vol 23, Iss 1, Pp 1-16 (2022)
Abstract Background Many people living with chronic kidney disease (CKD) are iron deficient, even though they may not be anaemic. The Iron and Muscle study aims to evaluate whether iron supplementation reduces symptoms of fatigue, improves muscle met
Externí odkaz:
https://doaj.org/article/0daa2f397c71407bb52995d794f11dc4
Autor:
Fergus J. Caskey, Sunita Procter, Stephanie J. MacNeill, Julia Wade, Jodi Taylor, Leila Rooshenas, Yumeng Liu, Ammar Annaw, Karen Alloway, Andrew Davenport, Albert Power, Ken Farrington, Sandip Mitra, David C. Wheeler, Kristian Law, Helen Lewis-White, Yoav Ben-Shlomo, Will Hollingworth, Jenny Donovan, J. Athene Lane
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-15 (2022)
Abstract Background More than a third of the 65,000 people living with kidney failure in the UK attend a dialysis unit 2–5 times a week to have their blood cleaned for 3–5 h. In haemodialysis (HD), toxins are removed by diffusion, which can be en
Externí odkaz:
https://doaj.org/article/2e9640d88ee64f2c8aa99c82de9004ab
Autor:
Michele Provenzano, Niels Jongs, Priya Vart, Bergur V. Stefánsson, Glenn M. Chertow, Anna Maria Langkilde, John J.V. McMurray, Ricardo Correa-Rotter, Peter Rossing, C. David Sjöström, Robert D. Toto, David C. Wheeler, Hiddo J.L. Heerspink
Publikováno v:
Kidney International Reports, Vol 7, Iss 3, Pp 436-443 (2022)
Introduction: Mineralocorticoid receptor antagonists (MRAs) and sodium–glucose cotransporter-2 (SGLT2) inhibitors reduce the risk of kidney failure in chronic kidney disease (CKD). We performed an analysis of the Dapagliflozin and Prevention of Adv
Externí odkaz:
https://doaj.org/article/1ea3200adb9746dca4e6abb643d67f2e
Autor:
Nicole Evangelidis, Benedicte Sautenet, Magdalena Madero, Allison Tong, Gloria Ashuntantang, Laura Cortes Sanabria, Ian H. de Boer, Samuel Fung, Daniel Gallego, Andrew S. Levey, Adeera Levin, Eduardo Lorca, Ikechi G. Okpechi, Patrick Rossignol, Laura Sola, Tim Usherwood, David C. Wheeler, Yeoungjee Cho, Martin Howell, Chandana Guha, Nicole Scholes-Robertson, Katherine Widders, Andrea Matus Gonzalez, Armando Teixeira-Pinto, Andrea K. Viecelli, Amelie Bernier-Jean, Samaya Anumudu, Louese Dunn, Martin Wilkie, Jonathan C. Craig, on behalf of the SONG-CKD Investigators
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-8 (2021)
Abstract Background Globally, over 1.2 million people die from chronic kidney disease (CKD) every year. Patients with CKD are up to 10 times more likely to die prematurely than progress to kidney failure requiring kidney replacement therapy. The burd
Externí odkaz:
https://doaj.org/article/5c1520d43d134097835d130e24af59b3